Glaxo Smith Kline Stop Smoking Aid

Stop Smoking Aid

This stop smoking aid is a nicotine polacrilex lozenge formulated to help reduce withdrawal symptoms, including nicotine cravings, while quitting smoking. It may fit buyers looking for a mint-flavored option to support smoking cessation in a straightforward lozenge format. Each lozenge has 4 milligrams of nicotine polacrilex.

Good Fit For

• Smoking cessation programs
• Buyers seeking a nicotine lozenge option
• Facilities or workplaces supporting quit-smoking efforts

Key Features

• Nicotine polacrilex lozenges help reduce withdrawal symptoms, including nicotine cravings
• Lozenge format offers a simple stop smoking aid option
• Ice mint flavor adds a refreshing taste during use
• Each lozenge has 4 milligrams of nicotine polacrilex
• Carton quantity is 20, which can help with planned purchasing

Applications and Usage

• Helping manage nicotine cravings while quitting smoking
• Supporting smoking cessation efforts with a mint-flavored lozenge
• Stocking a stop smoking aid for workplace or facility wellness needs

Packaging and Handling

• Packaging: CT.
• This product is a lozenge, so buyers comparing gum or patch formats may want to confirm preferred delivery form.
• Flavor may matter for adherence, and this option is ice mint.
• Strength matters in nicotine replacement choices; this lozenge has 4 milligrams of nicotine polacrilex each.

FAQ

• How does this stop smoking aid help during quitting? These nicotine polacrilex lozenges are intended to reduce withdrawal symptoms, including nicotine cravings, to help manage the challenge of quitting smoking.
• What flavor is the lozenge? This lozenge comes in an ice mint flavor.
• How much nicotine polacrilex is in each lozenge? Each lozenge has 4 milligrams of nicotine polacrilex.
• Is this a lozenge or another stop smoking format? This product is a nicotine polacrilex lozenge.

From Glaxo Smith Kline.